Neuronal nicotinic acetylcholine receptors (nAChRs) are a family of ligand
gated ion channels which are widely distributed in the human brain. Multipl
e subtypes of these receptors exist, each with individual pharmacological a
nd functional profiles. They mediate the effects of nicotine, a widely used
drug of abuse, are involved in a number of physiological and behavioural p
rocesses and are additionally implicated in a number of pathological condit
ions such as Alzheimer's disease, Parkinson's disease and schizophrenia. Th
e nAChRs have a pentameric structure composed of five membrane spanning sub
units, of which nine different types have thus far been identified and clon
ed. The multiple subunits identified provide the basis for the heterogeneit
y of structure and function observed in the nAChR subtypes and are responsi
ble for the individual characteristics of each. A substantial amount of inf
ormation on human nAChR structure and function has come from studies on neu
roblastoma cell lines which naturally express nAChRs and from recombinant n
AChRs expressed in Xenopus oocytes. In vitro brain nAChR distribution can b
e mapped with a number of appropriate agonist and antagonist radioligands a
nd subunit distribution may be mapped by in situ hybridization using subuni
t specific mRNA probes. Receptor distribution in the living human brain can
be studied with noninvasive imaging techniques such as PET and SPECT, with
a significant reduction in nAChRs in the brains of Alzheimer's patients ha
ving been identified with [C-11] nicotine in PET studies. Despite the signi
ficant body of knowledge now accumulated about nAChRs, much remains to be e
lucidated. This review will attempt to describe the current knowledge on th
e nAChR subtypes in the human brain, their functional roles and neuropathol
ogical involvement. (C) 2000 Elsevier Science Ltd. All rights reserved.